Page 6 - கண்டம் ஸ்டாக் பரிமாற்றம் நம்பிக்கை நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article NEW  YORK, July 1, 2021 /PRNewswire/ Orion Biotech Opportunities Corp. (Nasdaq: ORIAU) (the Company or us ) announced that, commencing July 2, 2021, holders of the units sold in the Company s initial public offering of 20,000,000 units, completed on May 17, 2021, may elect to separately trade the Class A ordinary shares and warrants included in the units. Those units that are not separated at the election of the holder will continue to trade on the Nasdaq Stock Market LLC ( Nasdaq ) under the symbol ORIAU, and the Class A ordinary shares and warrants that are separated will trade on the Nasdaq under the symbols ORIA and ORIAW, respectively. Holders of the units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company s transfer agent, in order to separate the units into Class A ordinary shares and warrants.

United statesMichael dellChrystyna bedrij stecykJames huangOrion biotech opportunities corpPrnewswire orion biotech opportunities corpCantor fitzgerald coContinental stock transfer trust companyExchange commissionSecurities exchangeNasdaq stock marketBiotech opportunitiesContinental stock transferTrust companyChief executive officerNorth american